

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular extravasation (GO:0045123) | 6.41414820 |
| 2 | regulation of chemokine biosynthetic process (GO:0045073) | 5.89144079 |
| 3 | macrophage differentiation (GO:0030225) | 5.79559171 |
| 4 | cytokine biosynthetic process (GO:0042089) | 5.50157462 |
| 5 | interkinetic nuclear migration (GO:0022027) | 5.12968564 |
| 6 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.89588856 |
| 7 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.86729395 |
| 8 | negative regulation of interleukin-8 production (GO:0032717) | 4.55537800 |
| 9 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.48464515 |
| 10 | cytokine metabolic process (GO:0042107) | 4.46924312 |
| 11 | positive regulation of histone deacetylation (GO:0031065) | 4.40560175 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.40235505 |
| 13 | histone H3-K9 modification (GO:0061647) | 4.39410836 |
| 14 | histone H3-K9 methylation (GO:0051567) | 4.36788279 |
| 15 | negative regulation of phagocytosis (GO:0050765) | 4.26808006 |
| 16 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.16264610 |
| 17 | regulation of growth of symbiont in host (GO:0044126) | 4.16264610 |
| 18 | negative regulation of growth of symbiont in host (GO:0044130) | 4.16264610 |
| 19 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.16264610 |
| 20 | mannose metabolic process (GO:0006013) | 4.11692443 |
| 21 | neutrophil mediated immunity (GO:0002446) | 4.07093449 |
| 22 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.04822355 |
| 23 | maintenance of protein location in nucleus (GO:0051457) | 4.02542273 |
| 24 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.91477927 |
| 25 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.85243285 |
| 26 | response to muramyl dipeptide (GO:0032495) | 3.81182706 |
| 27 | protein K48-linked deubiquitination (GO:0071108) | 3.77749635 |
| 28 | microglial cell activation (GO:0001774) | 3.73891890 |
| 29 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.73738474 |
| 30 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.72190969 |
| 31 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.72190969 |
| 32 | oocyte maturation (GO:0001556) | 3.70574122 |
| 33 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.67605560 |
| 34 | histone H4-K16 acetylation (GO:0043984) | 3.64181352 |
| 35 | histone H4-K8 acetylation (GO:0043982) | 3.63655900 |
| 36 | histone H4-K5 acetylation (GO:0043981) | 3.63655900 |
| 37 | phagocytosis (GO:0006909) | 3.62312299 |
| 38 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.60929563 |
| 39 | histone H3-K4 methylation (GO:0051568) | 3.56336935 |
| 40 | carnitine transmembrane transport (GO:1902603) | 3.54979904 |
| 41 | lipid translocation (GO:0034204) | 3.52995774 |
| 42 | phospholipid translocation (GO:0045332) | 3.52995774 |
| 43 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.45140061 |
| 44 | regulation of RNA export from nucleus (GO:0046831) | 3.39721788 |
| 45 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.31727996 |
| 46 | cellular response to ethanol (GO:0071361) | 3.30161893 |
| 47 | histone H3-K4 trimethylation (GO:0080182) | 3.29504477 |
| 48 | positive regulation of protein deacetylation (GO:0090312) | 3.27910047 |
| 49 | myeloid leukocyte mediated immunity (GO:0002444) | 3.23564946 |
| 50 | transcription from mitochondrial promoter (GO:0006390) | 3.22188355 |
| 51 | histone deubiquitination (GO:0016578) | 3.19187916 |
| 52 | amino-acid betaine transport (GO:0015838) | 3.15108338 |
| 53 | carnitine transport (GO:0015879) | 3.15108338 |
| 54 | chromatin silencing (GO:0006342) | 3.15036243 |
| 55 | base-excision repair, AP site formation (GO:0006285) | 3.14748210 |
| 56 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.13806954 |
| 57 | focal adhesion assembly (GO:0048041) | 3.13719985 |
| 58 | cell-substrate adherens junction assembly (GO:0007045) | 3.13719985 |
| 59 | cellular response to exogenous dsRNA (GO:0071360) | 3.13208316 |
| 60 | cellular response to virus (GO:0098586) | 3.11791435 |
| 61 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.05701555 |
| 62 | response to peptidoglycan (GO:0032494) | 3.05042548 |
| 63 | histone lysine methylation (GO:0034968) | 3.04455948 |
| 64 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.04401339 |
| 65 | histone H3-K36 demethylation (GO:0070544) | 3.03522444 |
| 66 | mRNA modification (GO:0016556) | 3.02752802 |
| 67 | response to misfolded protein (GO:0051788) | 3.02636255 |
| 68 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94002702 |
| 69 | snRNA metabolic process (GO:0016073) | 2.93854751 |
| 70 | regulation of histone deacetylation (GO:0031063) | 2.93826637 |
| 71 | negative regulation of multicellular organism growth (GO:0040015) | 2.92489936 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.92078217 |
| 73 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.90435670 |
| 74 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.88169414 |
| 75 | induction of positive chemotaxis (GO:0050930) | 2.88132054 |
| 76 | reactive oxygen species biosynthetic process (GO:1903409) | 2.85801164 |
| 77 | negative regulation of chemokine production (GO:0032682) | 2.83867945 |
| 78 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.82644303 |
| 79 | negative regulation of cell size (GO:0045792) | 2.80698631 |
| 80 | macrophage activation (GO:0042116) | 2.79021818 |
| 81 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.76430963 |
| 82 | positive regulation of developmental pigmentation (GO:0048087) | 2.73421881 |
| 83 | endosome to melanosome transport (GO:0035646) | 2.69219329 |
| 84 | endosome to pigment granule transport (GO:0043485) | 2.69219329 |
| 85 | pericardium development (GO:0060039) | 2.66747133 |
| 86 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.66741771 |
| 87 | snRNA processing (GO:0016180) | 2.66531659 |
| 88 | peptidyl-lysine methylation (GO:0018022) | 2.66521145 |
| 89 | adherens junction assembly (GO:0034333) | 2.64426131 |
| 90 | mRNA cleavage (GO:0006379) | 2.64413137 |
| 91 | positive regulation of DNA biosynthetic process (GO:2000573) | 2.58579261 |
| 92 | regulation of monocyte differentiation (GO:0045655) | 2.56551943 |
| 93 | regulation of mast cell degranulation (GO:0043304) | 2.56188907 |
| 94 | cell-substrate junction assembly (GO:0007044) | 2.55246478 |
| 95 | histone methylation (GO:0016571) | 2.52499904 |
| 96 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.49406516 |
| 97 | negative regulation of bone resorption (GO:0045779) | 2.47260337 |
| 98 | protein K63-linked deubiquitination (GO:0070536) | 2.45806854 |
| 99 | peptidyl-lysine dimethylation (GO:0018027) | 2.41333960 |
| 100 | regulation of chromatin binding (GO:0035561) | 2.40683198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 4.06270227 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.69614407 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.56168745 |
| 4 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.53418208 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.27942718 |
| 6 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.85188110 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.76994325 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.70994907 |
| 9 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.66728212 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.52873278 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.37847154 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.33350700 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.30901089 |
| 14 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.25724902 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.24394148 |
| 16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12618232 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10606826 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.06881086 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.05663387 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.04407347 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 1.98661181 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 1.86555490 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80981103 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79043978 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.79000444 |
| 26 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.76441937 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75300892 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72886725 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.72477173 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67774350 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67665790 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.65494190 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64816587 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61550056 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.61086690 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60757803 |
| 37 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.59232894 |
| 38 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58575509 |
| 39 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.52489975 |
| 40 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.51238860 |
| 41 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51166966 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.50796032 |
| 43 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.49966876 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49719270 |
| 45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.48672962 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47560654 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46940012 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43138027 |
| 49 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43022890 |
| 50 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.38939779 |
| 51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.37862641 |
| 52 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.36286276 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.34943979 |
| 54 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.34752434 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34227787 |
| 56 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33696600 |
| 57 | MYB_26560356_Chip-Seq_TH1_Human | 1.32200078 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29701496 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29378147 |
| 60 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.29002074 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24871483 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21968883 |
| 63 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.21127975 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20631141 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20453552 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19649565 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18747925 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18497855 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16615895 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16005057 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15291899 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14518029 |
| 73 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14503071 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14124712 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14034714 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14015723 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12255377 |
| 78 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.12181251 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11154906 |
| 80 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11062050 |
| 81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09771542 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.09508318 |
| 83 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09188851 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08565861 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08295810 |
| 86 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08016965 |
| 87 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07191749 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06131780 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04818015 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04173642 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02880146 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02843344 |
| 93 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02612962 |
| 94 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02376715 |
| 95 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00622814 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00495432 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99904810 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99812233 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98127826 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97169825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 2.91064394 |
| 2 | MP0001851_eye_inflammation | 2.73809027 |
| 3 | MP0005076_abnormal_cell_differentiation | 2.57122783 |
| 4 | MP0003172_abnormal_lysosome_physiology | 2.23107227 |
| 5 | MP0002160_abnormal_reproductive_system | 2.15579761 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 2.14306111 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.07922406 |
| 8 | MP0000015_abnormal_ear_pigmentation | 2.04085047 |
| 9 | MP0003303_peritoneal_inflammation | 10.9372277 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 1.98239348 |
| 11 | MP0002332_abnormal_exercise_endurance | 1.97801004 |
| 12 | MP0004130_abnormal_muscle_cell | 1.88642712 |
| 13 | MP0005058_abnormal_lysosome_morphology | 1.88409494 |
| 14 | MP0005451_abnormal_body_composition | 1.81407763 |
| 15 | MP0001663_abnormal_digestive_system | 1.81112741 |
| 16 | MP0001533_abnormal_skeleton_physiology | 1.77769005 |
| 17 | MP0001849_ear_inflammation | 1.72943940 |
| 18 | MP0002405_respiratory_system_inflammati | 1.69741207 |
| 19 | MP0003436_decreased_susceptibility_to | 1.69662257 |
| 20 | MP0005220_abnormal_exocrine_pancreas | 1.66661045 |
| 21 | MP0002419_abnormal_innate_immunity | 1.64714284 |
| 22 | MP0002060_abnormal_skin_morphology | 1.62422948 |
| 23 | MP0002396_abnormal_hematopoietic_system | 1.54353231 |
| 24 | MP0003656_abnormal_erythrocyte_physiolo | 1.47848600 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 1.42561797 |
| 26 | MP0005174_abnormal_tail_pigmentation | 1.39615544 |
| 27 | MP0005381_digestive/alimentary_phenotyp | 1.39434155 |
| 28 | MP0005025_abnormal_response_to | 1.36468249 |
| 29 | MP0003828_pulmonary_edema | 1.33724722 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.33063075 |
| 31 | MP0004381_abnormal_hair_follicle | 1.30837269 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.28099469 |
| 33 | MP0005409_darkened_coat_color | 1.27241092 |
| 34 | MP0001800_abnormal_humoral_immune | 1.26168080 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.25881829 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.25641910 |
| 37 | MP0003091_abnormal_cell_migration | 1.21976983 |
| 38 | MP0005083_abnormal_biliary_tract | 1.18287405 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.17854140 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.17278490 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.15370438 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.15370438 |
| 43 | MP0001819_abnormal_immune_cell | 1.14510134 |
| 44 | MP0005390_skeleton_phenotype | 1.12561848 |
| 45 | MP0003045_fibrosis | 1.12424875 |
| 46 | MP0004233_abnormal_muscle_weight | 1.10375622 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.09810772 |
| 48 | MP0003123_paternal_imprinting | 1.09096764 |
| 49 | MP0002970_abnormal_white_adipose | 1.08874131 |
| 50 | MP0001835_abnormal_antigen_presentation | 1.08277660 |
| 51 | MP0002398_abnormal_bone_marrow | 1.08059114 |
| 52 | MP0005360_urolithiasis | 1.06229623 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.05504548 |
| 54 | MP0001790_abnormal_immune_system | 1.05140348 |
| 55 | MP0005387_immune_system_phenotype | 1.05140348 |
| 56 | MP0005266_abnormal_metabolism | 1.03872387 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.03701902 |
| 58 | MP0002168_other_aberrant_phenotype | 1.01551915 |
| 59 | MP0004858_abnormal_nervous_system | 0.99639855 |
| 60 | MP0000685_abnormal_immune_system | 0.99402986 |
| 61 | MP0004510_myositis | 0.99242949 |
| 62 | MP0000716_abnormal_immune_system | 0.98660904 |
| 63 | MP0000733_abnormal_muscle_development | 0.94035006 |
| 64 | MP0002723_abnormal_immune_serum | 0.93006182 |
| 65 | MP0002089_abnormal_postnatal_growth/wei | 0.92977684 |
| 66 | MP0002722_abnormal_immune_system | 0.92413018 |
| 67 | MP0005389_reproductive_system_phenotype | 0.91847039 |
| 68 | MP0004147_increased_porphyrin_level | 0.91680920 |
| 69 | MP0009115_abnormal_fat_cell | 0.89312204 |
| 70 | MP0005375_adipose_tissue_phenotype | 0.89282212 |
| 71 | MP0005670_abnormal_white_adipose | 0.88069498 |
| 72 | MP0000703_abnormal_thymus_morphology | 0.86937173 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.86614598 |
| 74 | MP0002429_abnormal_blood_cell | 0.83690339 |
| 75 | MP0001845_abnormal_inflammatory_respons | 0.83221165 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.80870849 |
| 77 | MP0000678_abnormal_parathyroid_gland | 0.79546334 |
| 78 | MP0010368_abnormal_lymphatic_system | 0.78710739 |
| 79 | MP0000759_abnormal_skeletal_muscle | 0.78228497 |
| 80 | MP0009278_abnormal_bone_marrow | 0.77720243 |
| 81 | MP0005334_abnormal_fat_pad | 0.77676216 |
| 82 | MP0004043_abnormal_pH_regulation | 0.77206361 |
| 83 | MP0005023_abnormal_wound_healing | 0.76281919 |
| 84 | MP0001270_distended_abdomen | 0.74098380 |
| 85 | MP0003795_abnormal_bone_structure | 0.73916543 |
| 86 | MP0005310_abnormal_salivary_gland | 0.71281438 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.71266161 |
| 88 | MP0004087_abnormal_muscle_fiber | 0.70922672 |
| 89 | MP0002933_joint_inflammation | 0.70624715 |
| 90 | MP0000249_abnormal_blood_vessel | 0.69636733 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.68636786 |
| 92 | MP0000747_muscle_weakness | 0.68454580 |
| 93 | MP0000343_altered_response_to | 0.67812418 |
| 94 | MP0000689_abnormal_spleen_morphology | 0.67621742 |
| 95 | MP0004947_skin_inflammation | 0.64418243 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.61846433 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 0.61406725 |
| 98 | MP0000569_abnormal_digit_pigmentation | 0.61163533 |
| 99 | MP0008260_abnormal_autophagy | 0.60311330 |
| 100 | MP0001873_stomach_inflammation | 0.59077962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Follicular hyperkeratosis (HP:0007502) | 4.53880785 |
| 2 | Asymmetric septal hypertrophy (HP:0001670) | 4.49515037 |
| 3 | Abnormality of the fingertips (HP:0001211) | 4.47817733 |
| 4 | Cutaneous melanoma (HP:0012056) | 3.99128482 |
| 5 | Dysmetric saccades (HP:0000641) | 3.96890475 |
| 6 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.70906161 |
| 7 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.70906161 |
| 8 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.70906161 |
| 9 | Loss of speech (HP:0002371) | 3.64480549 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.60067945 |
| 11 | Mucopolysacchariduria (HP:0008155) | 3.60067945 |
| 12 | Thrombocytosis (HP:0001894) | 3.50191635 |
| 13 | Neonatal hypoglycemia (HP:0001998) | 3.40984246 |
| 14 | Asymmetry of the thorax (HP:0001555) | 3.37967645 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.30105762 |
| 16 | Genetic anticipation (HP:0003743) | 3.16233427 |
| 17 | Broad face (HP:0000283) | 3.13553295 |
| 18 | Lip pit (HP:0100267) | 2.97598464 |
| 19 | Ureteral stenosis (HP:0000071) | 2.97400809 |
| 20 | Persistence of primary teeth (HP:0006335) | 2.92761542 |
| 21 | Urethral obstruction (HP:0000796) | 2.90467383 |
| 22 | Thoracic kyphosis (HP:0002942) | 2.89131348 |
| 23 | Spondylolisthesis (HP:0003302) | 2.83511593 |
| 24 | Long eyelashes (HP:0000527) | 2.82949342 |
| 25 | Soft skin (HP:0000977) | 2.80802137 |
| 26 | Poor head control (HP:0002421) | 2.75777617 |
| 27 | Self-mutilation (HP:0000742) | 2.66707204 |
| 28 | Distal lower limb amyotrophy (HP:0008944) | 2.65386945 |
| 29 | Ureteral obstruction (HP:0006000) | 2.63510391 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62561589 |
| 31 | Acute lymphatic leukemia (HP:0006721) | 2.60711456 |
| 32 | Supernumerary nipples (HP:0002558) | 2.60196252 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55936635 |
| 34 | Natal tooth (HP:0000695) | 2.55144009 |
| 35 | Abnormality of the thoracic spine (HP:0100711) | 2.50608884 |
| 36 | Granulocytopenia (HP:0001913) | 2.47459719 |
| 37 | Lymphangioma (HP:0100764) | 2.44146512 |
| 38 | Ovoid vertebral bodies (HP:0003300) | 2.41801059 |
| 39 | Bladder diverticulum (HP:0000015) | 2.40026570 |
| 40 | Visual hallucinations (HP:0002367) | 2.34762054 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.31150961 |
| 42 | Sparse lateral eyebrow (HP:0005338) | 2.27292776 |
| 43 | Cerebral aneurysm (HP:0004944) | 2.26986170 |
| 44 | Abnormality of the columella (HP:0009929) | 2.20597471 |
| 45 | Hyperlipoproteinemia (HP:0010980) | 2.20252883 |
| 46 | Obstructive sleep apnea (HP:0002870) | 2.16733916 |
| 47 | Periodontitis (HP:0000704) | 2.15099543 |
| 48 | Joint stiffness (HP:0001387) | 2.14187244 |
| 49 | Eosinophilia (HP:0001880) | 2.13813064 |
| 50 | Cervical subluxation (HP:0003308) | 2.12814228 |
| 51 | Prominent nose (HP:0000448) | 2.07008995 |
| 52 | Visceral angiomatosis (HP:0100761) | 2.05028931 |
| 53 | Long foot (HP:0001833) | 2.03650549 |
| 54 | Short chin (HP:0000331) | 2.03384007 |
| 55 | Disproportionate tall stature (HP:0001519) | 2.02918519 |
| 56 | Genu recurvatum (HP:0002816) | 2.02678772 |
| 57 | Colitis (HP:0002583) | 2.01320688 |
| 58 | Ulnar deviation of the wrist (HP:0003049) | 2.01306872 |
| 59 | Rib fusion (HP:0000902) | 2.01159366 |
| 60 | Impaired smooth pursuit (HP:0007772) | 2.00456630 |
| 61 | Hypertriglyceridemia (HP:0002155) | 1.99310054 |
| 62 | Narrow palate (HP:0000189) | 1.97927525 |
| 63 | Bronchomalacia (HP:0002780) | 1.96938634 |
| 64 | Anal stenosis (HP:0002025) | 1.96057047 |
| 65 | Bicuspid aortic valve (HP:0001647) | 1.95604591 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 1.94590443 |
| 67 | Lower limb amyotrophy (HP:0007210) | 1.91214865 |
| 68 | Abnormality of carpal bone ossification (HP:0006257) | 1.89159386 |
| 69 | Hemorrhage of the eye (HP:0011885) | 1.88070447 |
| 70 | Epiphyseal dysplasia (HP:0002656) | 1.87577757 |
| 71 | Long palpebral fissure (HP:0000637) | 1.87142878 |
| 72 | Hematochezia (HP:0002573) | 1.81350796 |
| 73 | Broad distal phalanx of finger (HP:0009836) | 1.78665896 |
| 74 | Spontaneous hematomas (HP:0007420) | 1.75105585 |
| 75 | Tracheomalacia (HP:0002779) | 1.74557402 |
| 76 | Protruding tongue (HP:0010808) | 1.74557180 |
| 77 | Dislocated radial head (HP:0003083) | 1.72043703 |
| 78 | Increased connective tissue (HP:0009025) | 1.71701837 |
| 79 | Flat face (HP:0012368) | 1.71300894 |
| 80 | Hemangiomatosis (HP:0007461) | 1.71252042 |
| 81 | Abnormal ossification of hand bones (HP:0005921) | 1.70721437 |
| 82 | Ulnar bowing (HP:0003031) | 1.70045154 |
| 83 | Hypoalphalipoproteinemia (HP:0003233) | 1.69173601 |
| 84 | Macroorchidism (HP:0000053) | 1.68163226 |
| 85 | Albinism (HP:0001022) | 1.67569342 |
| 86 | Large eyes (HP:0001090) | 1.66386200 |
| 87 | Germ cell neoplasia (HP:0100728) | 1.64912615 |
| 88 | Hyperacusis (HP:0010780) | 1.64900784 |
| 89 | Tented upper lip vermilion (HP:0010804) | 1.64467681 |
| 90 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.63492046 |
| 91 | Upper limb amyotrophy (HP:0009129) | 1.62570516 |
| 92 | Distal upper limb amyotrophy (HP:0007149) | 1.62570516 |
| 93 | Abnormality of eosinophils (HP:0001879) | 1.61111448 |
| 94 | Squamous cell carcinoma (HP:0002860) | 1.61063369 |
| 95 | Synophrys (HP:0000664) | 1.60866276 |
| 96 | Thin bony cortex (HP:0002753) | 1.60057864 |
| 97 | Overfolded helix (HP:0000396) | 1.59497976 |
| 98 | Abnormality of skull ossification (HP:0002703) | 1.59497156 |
| 99 | Plagiocephaly (HP:0001357) | 1.59284938 |
| 100 | Advanced eruption of teeth (HP:0006288) | 1.58626325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 7.93186360 |
| 2 | LATS1 | 5.33550657 |
| 3 | ERN1 | 3.88436605 |
| 4 | CDK12 | 3.85312814 |
| 5 | TRIB3 | 2.91703662 |
| 6 | MAP2K3 | 2.90849888 |
| 7 | NUAK1 | 2.15534167 |
| 8 | PIM2 | 2.12359083 |
| 9 | FRK | 1.94172643 |
| 10 | ICK | 1.82825490 |
| 11 | TLK1 | 1.67830573 |
| 12 | SIK1 | 1.57013691 |
| 13 | TNK2 | 1.53937057 |
| 14 | TGFBR2 | 1.49371304 |
| 15 | MAP3K13 | 1.41071357 |
| 16 | PRPF4B | 1.40430190 |
| 17 | CAMK1D | 1.29481094 |
| 18 | CDC42BPA | 1.29196593 |
| 19 | MTOR | 1.25443313 |
| 20 | MAPK4 | 1.24606025 |
| 21 | MAP4K1 | 1.21205391 |
| 22 | MAP2K6 | 1.16134657 |
| 23 | TYRO3 | 1.13627977 |
| 24 | BMX | 1.11971655 |
| 25 | MAP3K6 | 1.00481924 |
| 26 | SIK2 | 0.98165279 |
| 27 | BLK | 0.97467168 |
| 28 | MARK2 | 0.95165069 |
| 29 | ACVR1B | 0.94072065 |
| 30 | MAP3K7 | 0.93785736 |
| 31 | TTN | 0.92652114 |
| 32 | CAMK1G | 0.91908115 |
| 33 | STK24 | 0.91872980 |
| 34 | TAOK1 | 0.89511932 |
| 35 | FGFR2 | 0.88029209 |
| 36 | TRPM7 | 0.87226029 |
| 37 | PRKD2 | 0.84852841 |
| 38 | MAP3K10 | 0.83832861 |
| 39 | TBK1 | 0.83543539 |
| 40 | MAP3K14 | 0.83011390 |
| 41 | EEF2K | 0.82235168 |
| 42 | GRK6 | 0.80406487 |
| 43 | WNK1 | 0.80033373 |
| 44 | STK3 | 0.79563998 |
| 45 | MAP3K11 | 0.75038687 |
| 46 | IKBKB | 0.73759402 |
| 47 | ZAP70 | 0.73264310 |
| 48 | GRK7 | 0.71570302 |
| 49 | IRAK4 | 0.69424695 |
| 50 | IRAK2 | 0.68958449 |
| 51 | SMG1 | 0.68868110 |
| 52 | PKN2 | 0.67021500 |
| 53 | IRAK3 | 0.66963567 |
| 54 | CHUK | 0.65955976 |
| 55 | MAPK7 | 0.65170068 |
| 56 | PDPK1 | 0.63328420 |
| 57 | MAPK11 | 0.59474785 |
| 58 | PTK6 | 0.57159885 |
| 59 | MAPK8 | 0.56953620 |
| 60 | PDK1 | 0.55443772 |
| 61 | MAP3K3 | 0.52688778 |
| 62 | FGFR3 | 0.52282229 |
| 63 | MELK | 0.51190910 |
| 64 | RPS6KC1 | 0.50120913 |
| 65 | RPS6KL1 | 0.50120913 |
| 66 | HCK | 0.50104725 |
| 67 | RPS6KA6 | 0.50078101 |
| 68 | FGFR4 | 0.48827818 |
| 69 | MAP3K1 | 0.48498950 |
| 70 | FES | 0.48290606 |
| 71 | INSRR | 0.48001798 |
| 72 | BTK | 0.47027403 |
| 73 | PRKAA2 | 0.46362445 |
| 74 | MAP2K4 | 0.45653889 |
| 75 | IKBKE | 0.44721537 |
| 76 | HIPK2 | 0.44534894 |
| 77 | JAK1 | 0.44227095 |
| 78 | ADRBK2 | 0.43029921 |
| 79 | PDGFRB | 0.42415537 |
| 80 | TAOK2 | 0.41784858 |
| 81 | AKT3 | 0.41381280 |
| 82 | PIM1 | 0.41373417 |
| 83 | PRKAA1 | 0.40658347 |
| 84 | BRD4 | 0.38139764 |
| 85 | KIT | 0.36753222 |
| 86 | MAPK10 | 0.36452647 |
| 87 | RAF1 | 0.36324627 |
| 88 | TYK2 | 0.36230670 |
| 89 | MOS | 0.35321130 |
| 90 | ADRBK1 | 0.34760713 |
| 91 | SYK | 0.33180354 |
| 92 | STK11 | 0.32903425 |
| 93 | WNK4 | 0.31903334 |
| 94 | BMPR1B | 0.30699582 |
| 95 | MAPKAPK3 | 0.30064704 |
| 96 | MAP2K2 | 0.29983993 |
| 97 | RIPK1 | 0.28672246 |
| 98 | PAK2 | 0.28494746 |
| 99 | CSF1R | 0.27655566 |
| 100 | JAK3 | 0.26731340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.98020273 |
| 2 | Lysine degradation_Homo sapiens_hsa00310 | 2.75942715 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.70477381 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.49327642 |
| 5 | VEGF signaling pathway_Homo sapiens_hsa04370 | 2.20291035 |
| 6 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.86719845 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.70032856 |
| 8 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.63187252 |
| 9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62775626 |
| 10 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.60421126 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48718107 |
| 12 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.47644027 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46426066 |
| 14 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45861211 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44060260 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43637858 |
| 17 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.38871408 |
| 18 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.32728872 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.29629442 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27563802 |
| 21 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.25937727 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25780790 |
| 23 | Bladder cancer_Homo sapiens_hsa05219 | 1.23029651 |
| 24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22687246 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22537241 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.20873127 |
| 27 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.20438887 |
| 28 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18248808 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18058357 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16677077 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15924471 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13539068 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12554108 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.10446286 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09857461 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09628242 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08149789 |
| 38 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.04755781 |
| 39 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96394426 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94870265 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93111089 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92757631 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 0.90901255 |
| 44 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90654703 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.90034437 |
| 46 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88857515 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.88493863 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.88398121 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87728902 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87558312 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87231086 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86364209 |
| 53 | Melanoma_Homo sapiens_hsa05218 | 0.85586919 |
| 54 | Malaria_Homo sapiens_hsa05144 | 0.85047678 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.84865672 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83691681 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83237520 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82135583 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81036560 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81017988 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.77155823 |
| 62 | Prostate cancer_Homo sapiens_hsa05215 | 0.76560945 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75694176 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74181045 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73866143 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72452654 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71851178 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71548332 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71229167 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68329586 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66032032 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66012087 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63435266 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62738524 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61842019 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61668164 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.61037940 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60387816 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59965468 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.59828589 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59076409 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59045336 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57823360 |
| 84 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57173763 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57025943 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.56346309 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53967178 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.53895853 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52387625 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.52059234 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.51059381 |
| 92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50785219 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48882717 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48835705 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48376193 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46851583 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46070820 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45001653 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.44396041 |
| 100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43523233 |

